侵入式激光针灸靶向肌肉:帕金森病模型神经保护新策略
本研究在MPTP诱导的帕金森病小鼠模型中,探讨侵入式激光针灸(ILA)的保护作用。830 nm ILA可改善运动表现、保护黑质纹状体多巴胺能神经元、降低神经炎症,并引起肌肉代谢物变化;侵入式激光优于非侵入式,利多卡因预处理未阻断其效应。
要点
- 830 nm侵入式激光针灸可改善帕金森病小鼠运动功能并保护多巴胺能神经元。
- 该疗法降低脑内α-突触核蛋白、凋亡蛋白及炎症因子,增加抗炎因子。
- 侵入式激光效果优于非侵入式,且利多卡因神经阻滞未阻断其效应。
核心结论
- 830 nm侵入式激光针灸通过保护多巴胺能神经元和减少脑内神经炎症改善帕金森病模型小鼠症状。
- 肌肉代谢物如葡萄糖和半乳糖的变化与运动功能改善相关。
研究设计与样本
- 研究采用MPTP诱导的帕金森病小鼠模型,分别以830 nm或650 nm侵入式激光针灸治疗。
- 评估黑质纹状体TH免疫反应性、脑内神经炎症标志物及肌肉代谢组学,并比较侵入式与非侵入式激光及利多卡因神经阻滞的影响。
主要发现
- 830 nm侵入式激光针灸显著改善运动表现并增加黑质纹状体TH阳性免疫反应性。
- 830 nm侵入式激光针灸降低α-突触核蛋白、凋亡蛋白和炎症因子水平,增加抗炎因子,并减少星形胶质细胞和小胶质细胞活化。
- 肌肉代谢组学显示组间聚类分明,葡萄糖和半乳糖等代谢物显著变化并与运动功能改善相关。
- 侵入式激光治疗比非侵入式更有效,利多卡因预处理未阻断其效应。
临床怎么用
- 该研究为帕金森病提供了一种结合针灸与光生物调节的潜在治疗策略,需进一步临床研究优化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Parkinson's disease (PD) affects 1-2% of the global population and presents significant therapeutic challenges. Due to the limitations of existing treatments, there is a pressing need for alternative approaches. This study investigated the effects of invasive laser acupuncture (ILA), which combines acupuncture and photobiomodulation. In this method, optical fibers are inserted into the muscle layers of the acupoint to enhance therapeutic outcomes. Mice with MPTP-induced PD were treated with ILA at 830 nm or 650 nm. Protective effects of nigrostriatal dopaminergic neurons and fibers were assessed by examining TH immunoreactivity in the brain. Neuroinflammation markers in the brain and muscle metabolomic profiles were also analyzed. Comparisons between invasive and non-invasive laser application, as well as the impact of nerve blocking with lidocaine, were also evaluated. ILA at 830 nm (ILA830) significantly improved motor performance and increased the nigrostriatal TH-positive immunoreactivities. It reduced the levels of α-synuclein, apoptotic proteins, and inflammatory cytokines, while increasing anti-inflammatory in the brain. ILA830 also decreased nigrostriatal astrocyte and microglia activation. Muscle metabolomic analysis showed distinct group clustering and significant changes in metabolites like glucose and galactose, correlating with improved motor functions. Invasive laser treatment was more effective than non-invasive, and lidocaine pre-treatment did not block its effects. ILA at 830 nm effectively ameliorates PD symptoms by protecting dopaminergic neurons, and reducing neuroinflammation in the brain. Muscle metabolomic changes by ILA830, such as increased glucose and galactose, correlate with motor improvement. This approach offers a promising strategy for PD treatment, warranting further research to optimize its use in clinical settings.
引用
- Jeon H, Oh JY, Ahn S, et al. Invasive laser acupuncture targeting muscle: a novel approach to protect dopaminergic neurons and reduce neuroinflammation in a brain of Parkinson's disease model. Chin Med. 2025. PMID: 40336061. doi:10.1186/s13020-025-01104-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。